Literature DB >> 30094526

Diastolic heart dysfunction is correlated with CTG repeat length in myotonic dystrophy type 1.

Jin-Sung Park1, Namkyun Kim2, Donghwi Park3.   

Abstract

The aims of this study were to investigate the correlations of tri-nucleotide (CTG) repeat length with detailed echocardiography (ECHO) parameters that represent myocardial function and to find a relationship between heart function and CTG repeat length in adult-onset myotonic dystrophy type 1 (DM1). In this study, clinical data for patients with DM1, including age, onset age, CTG repeat length, Medical Research Council sum score (MRCSS), and 6-min walking test (6MWT), were recorded. In addition, ECHO parameters and cardiac conduction abnormalities were evaluated. Among the cardiac parameters, the EA ratio and left ventricular end-diastolic dimension (LVEDD) were significantly correlated with the CTG repeat length (p < 0.05). Interventricular septal thickness at end-diastole was also significantly correlated with the 6MWT in a multivariate linear regression model (p < 0.05). In conclusion, motor function (MRCSS and 6MWT) and CTG repeat length significantly correlated with LV diastolic dysfunction in patients with DM1. More emphasis should be given to diastolic dysfunction, which is currently under-recognized, when evaluating patients with DM1 with no abnormalities in routine electrocardiography studies. Lastly, well-designed and longitudinal studies are warranted to characterize and understand the pathophysiology of diastolic dysfunction in DM1.

Entities:  

Keywords:  Aerobic exercise; CTG repeat; Left ventricle diastolic dysfunction; Myocardial dysfunction; Myotonia; Myotonic dystrophy type 1

Mesh:

Substances:

Year:  2018        PMID: 30094526     DOI: 10.1007/s10072-018-3530-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  31 in total

1.  Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.

Authors:  Zhen Zhi Tang; Viktor Yarotskyy; Lan Wei; Krzysztof Sobczak; Masayuki Nakamori; Katy Eichinger; Richard T Moxley; Robert T Dirksen; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2011-12-02       Impact factor: 6.150

2.  Quantitative Assessment of Trunk Muscles Involvement in Patients with Myotonic Dystrophy Type 1 Using a Whole Body Muscle Magnetic Resonance Imaging.

Authors:  Donghwi Park; Jin-Sung Park
Journal:  Eur Neurol       Date:  2017-03-14       Impact factor: 1.710

Review 3.  Myocardial fibrosis: functional significance and regulatory factors.

Authors:  K T Weber; C G Brilla; J S Janicki
Journal:  Cardiovasc Res       Date:  1993-03       Impact factor: 10.787

4.  Haplotype analysis of the myotonic dystrophy type 1 (DM1) locus in the Korean population.

Authors:  Min-Jung Kwon; Seung-Tae Lee; Byoung Joon Kim; Duk Hyun Sung; Jong-Won Kim; Chang-Seok Ki
Journal:  Ann Clin Lab Sci       Date:  2010       Impact factor: 1.256

5.  Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue.

Authors:  Joke S Kalkman; Machiel J Zwarts; Maartje L Schillings; Baziel G M van Engelen; Gijs Bleijenberg
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

6.  Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo.

Authors:  Antonella Moreo; Giuseppe Ambrosio; Benedetta De Chiara; Min Pu; Tam Tran; Francesco Mauri; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-03       Impact factor: 7.792

7.  Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I.

Authors:  Deepak Bhakta; Miriam R Lowe; William J Groh
Journal:  Am Heart J       Date:  2004-02       Impact factor: 4.749

8.  Treatment of Guillain-Barré syndrome with high-dose gammaglobulin.

Authors:  R P Kleyweg; F G van der Meché; J Meulstee
Journal:  Neurology       Date:  1988-10       Impact factor: 9.910

9.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

Review 10.  What mechanisms underlie diastolic dysfunction in heart failure?

Authors:  David A Kass; Jean G F Bronzwaer; Walter J Paulus
Journal:  Circ Res       Date:  2004-06-25       Impact factor: 17.367

View more
  3 in total

1.  Outcome of Myotonic Dystrophy 1 Depends on Comprehensive Diagnostic and Therapeutic Management.

Authors:  Josef Finsterer; Radu Nicolae Ciudin; Nic Claudiu Dragatoiu; Sergiu Sipos; Dan Nicolae Tesloianu; Andreea Maria Ursaru; Ioan Mircea Coman
Journal:  Maedica (Bucur)       Date:  2020-06

2.  Myotonic dystrophy type 1 presenting with dyspnea: A case report.

Authors:  Yu-Xi Jia; Chun-Ling Dong; Jia-Wei Xue; Xiao-Qin Duan; Ming-Yu Xu; Xiao-Min Su; Ping Li
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

3.  Case Report: Severe Peripartum Cardiac Disease in Myotonic Dystrophy Type 1.

Authors:  Georgia Besant; Pierre R Bourque; Ian C Smith; Sharon Chih; Mariana M Lamacie; Ari Breiner; Jocelyn Zwicker; Hanns Lochmüller; Jodi Warman-Chardon
Journal:  Front Cardiovasc Med       Date:  2022-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.